C. Lagrou

1.5k total citations
19 papers, 1.3k citations indexed

About

C. Lagrou is a scholar working on Molecular Biology, Genetics and Cell Biology. According to data from OpenAlex, C. Lagrou has authored 19 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Genetics and 3 papers in Cell Biology. Recurrent topics in C. Lagrou's work include Virus-based gene therapy research (5 papers), RNA and protein synthesis mechanisms (5 papers) and RNA Research and Splicing (5 papers). C. Lagrou is often cited by papers focused on Virus-based gene therapy research (5 papers), RNA and protein synthesis mechanisms (5 papers) and RNA Research and Splicing (5 papers). C. Lagrou collaborates with scholars based in France, United States and Germany. C. Lagrou's co-authors include D. Stéhelin, Simon Saule, Martine F. Roussel, Jean‐Luc Coll, Anne Gégonne, Dominique Leprince, Thomas Graf, Hartmut Beug, Corinne Rommens and C. de Taisne and has published in prestigious journals such as Nature, Genes & Development and The EMBO Journal.

In The Last Decade

C. Lagrou

19 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Lagrou France 14 893 331 291 176 170 19 1.3k
J A Lautenberger United States 11 789 0.9× 256 0.8× 302 1.0× 108 0.6× 204 1.2× 17 1.2k
Gudrun Hüper United States 21 677 0.8× 502 1.5× 136 0.5× 162 0.9× 396 2.3× 29 1.3k
Roberta K. Reynolds United States 14 1.0k 1.1× 570 1.7× 240 0.8× 266 1.5× 431 2.5× 16 1.7k
R Ishizaki Japan 14 537 0.6× 223 0.7× 120 0.4× 88 0.5× 269 1.6× 26 1000
Dorothy L. Buchhagen United States 17 702 0.8× 311 0.9× 156 0.5× 237 1.3× 643 3.8× 26 1.4k
Maureen O. Weeks United States 12 804 0.9× 469 1.4× 155 0.5× 65 0.4× 326 1.9× 16 1.2k
Y K Fung United States 17 834 0.9× 288 0.9× 148 0.5× 112 0.6× 536 3.2× 22 1.3k
R A Bosselman United States 15 826 0.9× 691 2.1× 405 1.4× 37 0.2× 217 1.3× 26 1.6k
Ian B. Pragnell United Kingdom 25 936 1.0× 405 1.2× 819 2.8× 169 1.0× 785 4.6× 62 2.2k
Geoff Symonds Australia 25 1.5k 1.7× 648 2.0× 409 1.4× 109 0.6× 389 2.3× 98 2.2k

Countries citing papers authored by C. Lagrou

Since Specialization
Citations

This map shows the geographic impact of C. Lagrou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Lagrou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Lagrou more than expected).

Fields of papers citing papers by C. Lagrou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Lagrou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Lagrou. The network helps show where C. Lagrou may publish in the future.

Co-authorship network of co-authors of C. Lagrou

This figure shows the co-authorship network connecting the top 25 collaborators of C. Lagrou. A scholar is included among the top collaborators of C. Lagrou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Lagrou. C. Lagrou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Dugimont, Thierry, Éric Adriaenssens, Séverine Lottin, et al.. (1998). The H19 TATA-less promoter is efficiently repressed by wild-type tumor suppressor gene product p53. Oncogene. 16(18). 2395–2401. 92 indexed citations
2.
Pelczar, Hélène, et al.. (1996). The 5' part of the human H19 RNA contains cis-acting elements hampering its translatability.. PubMed. 42(8). 1159–72. 21 indexed citations
3.
Adelmant, Guillaume, Brigitte Quatannens, C. Lagrou, et al.. (1994). In vivo cooperation of two nuclear oncogenic proteins, P135gag-myb-ets and p61/63myc, leads to transformation and immortalization of chicken myelomonocytic cells. Journal of Virology. 68(4). 2097–2107. 1 indexed citations
4.
Marer, Nadia Le, Vincent Laudet, E. C. Svensson, et al.. (1992). The c-Ha-ras oncogene induces increased expression of β-galactoside α-2,6-sialyltransferase in rat fibroblast (FR3T3) cells. Glycobiology. 2(1). 49–56. 72 indexed citations
5.
Lassalle, Philippe, C. Lagrou, Yves Delneste, et al.. (1992). Human endothelial cells transfected by SV40 T antigens: characterization and potential use as a source of normal endothelial factors. European Journal of Immunology. 22(2). 425–431. 32 indexed citations
6.
7.
Marer, Nadia Le, Vincent Laudet, C. Lagrou, et al.. (1991). [Modifications of sialylation in BHK 21/C13 cells after in vitro transfection by c-Ha-ras human oncogene].. PubMed. 312(7). 293–300. 4 indexed citations
8.
Boulukos, Kim E., Philippe Pognonec, Eric Sariban, et al.. (1990). Rapid and transient expression of Ets2 in mature macrophages following stimulation with cMGF, LPS, and PKC activators.. Genes & Development. 4(3). 401–409. 47 indexed citations
9.
Duterque‐Coquillaud, Martine, C. Lagrou, Brigitte Debuire, et al.. (1989). A single amino-acid substitution in the DNA-binding domain of the myb oncogene confers a thermolabile phenotype to E26-transformed myeloid cells.. PubMed. 5(2). 137–41. 6 indexed citations
10.
Ferré, F., Patricia E. Martin, C. Lagrou, et al.. (1987). The human c-myc exon 1 product: preparation of antisera and analysis of its expression.. PubMed. 1(4). 387–93. 3 indexed citations
11.
Martin, Patrick, C. Henry, F. Ferré, et al.. (1986). Transformation of quail embryo fibroblasts by a retrovirus carrying a normal human c-myc gene.. The EMBO Journal. 5(7). 1529–1533. 30 indexed citations
12.
Ghysdael, Jacques, Anne Gégonne, Philippe Pognonec, et al.. (1986). Identification in chicken macrophages of a set of proteins related to, but distinct from, the chicken cellular c-ets-encoded protein p54c-ets.. The EMBO Journal. 5(9). 2251–2256. 25 indexed citations
13.
Saule, Simon, Patrick Martin, Anne Gégonne, et al.. (1984). Increased transcription of the c-myc oncogene in two methylcholanthrene-induced quail fibroblastic cell lines. Experimental Cell Research. 155(2). 496–506. 8 indexed citations
14.
Coll, Jean‐Luc, Simon Saule, Patrick Martin, et al.. (1983). The cellular oncogenes c-myc, c-myb and c-erb are transcribed in defined types of avian hematopoietic cells. Experimental Cell Research. 149(1). 151–162. 74 indexed citations
15.
Saule, Simon, Jean Coll, Marco Righi, et al.. (1983). Two different types of transcription for the myelocytomatosis viruses MH2 and CMII.. The EMBO Journal. 2(6). 805–809. 17 indexed citations
16.
Leprince, Dominique, Anne Gégonne, Jean‐Luc Coll, et al.. (1983). A putative second cell-derived oncogene of the avian leukaemia retrovirus E26. Nature. 306(5941). 395–397. 393 indexed citations
17.
Saule, Simon, Martine F. Roussel, C. Lagrou, & D. Stéhelin. (1981). Characterization of the oncogene (erb) of avian erythroblastosis virus and its cellular progenitor. Journal of Virology. 38(2). 409–419. 33 indexed citations
18.
Stéhelin, D., Simon Saule, Martine F. Roussel, et al.. (1980). Three New Types of Viral Oncogenes in Defective Avian Leukemia Viruses. I. Specific Nucleotide Sequences of Cellular Origin Correlate with Specific Transformation. Cold Spring Harbor Symposia on Quantitative Biology. 44(0). 1215–1223. 48 indexed citations
19.
Roussel, Martine F., Simon Saule, C. Lagrou, et al.. (1979). Three new types of viral oncogene of cellular origin specific for haematopoietic cell transformation. Nature. 281(5731). 452–455. 353 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J A Lautenberger Breakdown of academic impact, for papers by Gudrun Hüper Breakdown of academic impact, for papers by Roberta K. Reynolds Breakdown of academic impact, for papers by R Ishizaki Breakdown of academic impact, for papers by Dorothy L. Buchhagen Breakdown of academic impact, for papers by Maureen O. Weeks Breakdown of academic impact, for papers by Y K Fung Breakdown of academic impact, for papers by R A Bosselman Breakdown of academic impact, for papers by Ian B. Pragnell Breakdown of academic impact, for papers by Geoff Symonds
Rankless by CCL
2026